Arterial hyper-responsiveness to 5-hydroxytryptamine (5-HT) is a hallmark of hypertension, and plasma levels of free 5-HT are elevated in hypertension. We hypothesized that chronic administration of 5-HT would cause blood pressure to 1) rise in normotensive rats and 2) rise significantly more in hypertensive rats. The deoxycorticosterone acetate (DOCA)-salt hypertensive and sham normotensive rat were used. Animals were implanted with minipumps that delivered 5-HT (or vehicle) at a rate of 25 g/kg/min for 7 days. Free plasma 5-HT was elevated significantly by this protocol. Within 48 h, mean arterial blood pressure measured telemetrically decreased in sham (106 Ϯ 2 to 83 Ϯ 2 mm Hg) and in DOCA-salt hypertensive (166 Ϯ 9 to 112 Ϯ 3 mm Hg) rats; vehicle did not change blood pressure in either group. Ganglionic blockade (hexamethonium) reduced blood pressure to a greater magnitude in DOCA vehicle-administered rats (peak fall arterial pressure, 91 Ϯ 14 mm Hg) compared with DOCA 5-HT-administered rats (40 Ϯ 6 mm Hg). Maximal acetylcholine-induced (NO-dependent) relaxation in phenylephrine-contracted aortic strips was greater in 5-HTadministered (69.2 Ϯ 9.1% relaxation) versus vehicle-administered (39.7 Ϯ 14.2%) DOCA rats; aortic endothelial cell nitric oxide synthase expression was higher in the 5-HT-versus vehicle-administered DOCA-salt rats. In normotensive and DOCAsalt hypertensive rats, the nitric oxide synthase (NOS) inhibitor N -nitro-L-arginine (0.5 g/l in water) prevented the fall in blood pressure to 5-HT. We conclude that chronic exogenous 5-HT reduces blood pressure in normotensive and hypertensive rats through mechanisms critically dependent on NOS.Serotonin [5-hydroxytryptamine (5-HT)] was discovered and characterized over 60 years ago by the Italian scientist Erspamer (Erspamer and Asero, 1952) and by Irving Page (Rapport et al., 1948; Page and McCubbin, 1953a,b). In the periphery, 5-HT is made primarily in the enterochromaffin cells of the intestine. The circulatory system is exposed to 5-HT through aggregation of platelets (which take up and store a millimolar concentration of 5-HT), release from adrenergic nerves that have taken up 5-HT, and through direct exposure to 5-HT that is free in the blood. In many tissues, 5-HT is taken up and concentrated by the serotonin transporter (SERT) and is rapidly metabolized to an inactive metabolite, 5-hydroxyindole acetic acid (5-HIAA), by intracellular monoamine oxidase.5-HT was originally described as a substance derived from serum (sero) that increased the tone of smooth muscle (tonin). Because of the close association of the platelet with the blood vessel, there has been a long-standing question as to the role of 5-HT in controlling vascular tone and modifying blood pressure under normotensive and hypertensive conditions. Several findings suggest that 5-HT contributes to systemic hypertension. These include the following findings: 1) plasma levels (free) of 5-HT are elevated in experimental and human models of hypertension (Fetkovska et al., 1990;Carr...